Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
Clinical trial NCT01510119 · COMPLETED
Trial details
- NCT number
- NCT01510119
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2016-04-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.